By enhancing PI3K/Akt signaling, GPR30 activation might promote glucose uptake in peripheral tissues and inhibit excessive gluconeogenesis, thereby mitigating hyperglycemia and insulin resistance associated with an HFD. The gene discussed is GPER1; the disease is Insulin resistance.